🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Chen‐Yen Lin

Eli Lilly (United States)

ORCID: 0000-0003-0662-4079

Also affiliated with Public Health Ontario

Immunology and MicrobiologyMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: Rapid and sustained improvements in patient-reported signs and symptoms with ixekizumab in biologic-naive and TNF-inadequate responder patients with psoriatic arthritis.

7 citations

Dafna D. Gladman, Midori Goto, Julie Birt, Amanda M. Gellett, Chen‐Yen Lin +2 more